What is the usual adult dosage of nivolumab?
For adults, the nivolumab dose depends on the cancer type and the treatment schedule set by the prescribing label. Nivolumab is given either:
- by body weight (mg/kg) at specific intervals, or
- as a fixed amount (mg) with the same schedule.
Because the exact dose varies by indication (for example, different dosing is used for melanoma, lung cancer, renal cell carcinoma, head and neck cancer, and Hodgkin lymphoma), the safest way to confirm the correct regimen is to match the dosing to the specific condition and whether it is administered every 2 weeks or every 4 weeks.
How do you make sure you’re using the right nivolumab regimen?
To give the correct adult dosage, you typically need:
- the cancer type (indication),
- the treatment interval (often every 2 weeks or every 4 weeks),
- whether it’s being used as monotherapy or in combination with other drugs, and
- the patient’s relevant clinical factors (for example, renal/hepatic impairment can affect some combination plans, depending on the regimen).
Quick check: what info do you have?
If you tell me which indication you mean (for example, metastatic melanoma or non-small cell lung cancer) and the dosing interval you’ve been told (2-week or 4-week), I can restate the correct adult nivolumab dose for that regimen.